Colgate-Palmolive
1,699 hedge funds and large institutions have $52.1B invested in Colgate-Palmolive in 2022 Q4 according to their latest regulatory filings, with 190 funds opening new positions, 573 increasing their positions, 591 reducing their positions, and 68 closing their positions.
179% more first-time investments, than exits
New positions opened: 190 | Existing positions closed: 68
14% more call options, than puts
Call options by funds: $380M | Put options by funds: $333M
13% more capital invested
Capital invested by funds: $46.2B → $52.1B (+$5.94B)
5% more funds holding
Funds holding: 1,615 → 1,699 (+84)
0.11% more ownership
Funds ownership: 78.99% → 79.1% (+0.11%)
3% less repeat investments, than reductions
Existing positions increased: 573 | Existing positions reduced: 591
4% less funds holding in top 10
Funds holding in top 10: 24 → 23 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$251M |
| 2 |
BlackRock
New York
|
+$235M |
| 3 |
JP Morgan Chase
New York
|
+$213M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$178M |
| 5 |
Barclays
London,
United Kingdom
|
+$156M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$612M |
| 2 |
TCIM
TOMS Capital Investment Management
New York
|
-$240M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$185M |
| 4 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$184M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$173M |
CL Hedge Fund Activity: Q4 2022 in Review
1,699 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q4 2022, worth a combined $52.1B — up 13% from $46.2B a quarter earlier.
Buyers outnumbered sellers: 190 funds opened new CL positions and 68 closed out — a net gain of 122 holders — while 573 added to existing stakes and 591 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $251M. The largest seller was Bank of New York Mellon, cutting an estimated $612M.
- 1,699 institutional investors held Colgate-Palmolive (CL) as of Q4 2022, up from 1,615 in Q3 2022.
- Funds reported $52.1B of Colgate-Palmolive stock for Q4 2022, up 13% quarter-over-quarter.
- 190 funds opened new Colgate-Palmolive positions in Q4 2022 and 68 closed out, a net change of +122 holders.
- The largest Colgate-Palmolive buyer in Q4 2022 was Morgan Stanley, an estimated $251M added.
- The largest Colgate-Palmolive seller in Q4 2022 was Bank of New York Mellon, an estimated $612M sold.
Based on aggregated 13F filings for Q4 2022.